302440 — SK Bioscience Co Income Statement
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩651bn
Annual income statement for SK Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 929,001 | 456,726 | 369,506 | 267,545 | 651,368 |
| Cost of Revenue | |||||
| Gross Profit | 570,283 | 239,611 | 142,243 | 30,976 | 75,924 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 454,781 | 341,712 | 382,647 | 390,567 | 774,806 |
| Operating Profit | 474,220 | 115,014 | -13,141 | -123,022 | -123,438 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 471,128 | 141,733 | 7,327 | -89,107 | -85,860 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 355,139 | 122,452 | 22,318 | -50,117 | -56,173 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 355,139 | 122,452 | 22,318 | -53,881 | -57,424 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 355,139 | 122,452 | 22,318 | -53,881 | -57,424 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4,810 | 1,595 | 300 | -948 | -990 |
| Dividends per Share |